Johnson & Johnson
June 23, 2026
Theater 2
Type: Company Presentation
Focus Area:
Multiple Therapeutics
Johnson & Johnson is a global healthcare leader, committed to solving the toughest health challenges and transforming lives through research, development, manufacture and distribution of medicines and medical technologies. The company’s Innovative Medicine business advances breakthrough science and develops transformational treatments in areas like oncology, immunology, neuroscience, and cardiopulmonary. In MedTech, the company is focused on developing and delivering cardiovascular, surgery, and vision solutions. Visit jnj.com to learn more.
Company HQ City:
New Brunswick
Company HQ State:
NJ
Company HQ Country:
United States
Year Founded:
1886
Lead Product in Development:
Darzalex, Stelara, Tremfya, Imbruvica, Erleada, Remicade
CEO
Joaquin Duato
Development Phase of Lead Product
Multiple Products in Market
Exchange
JNJ
Ticker
JNJ
When you expect your next catalyst update?
N/A
What is your next catalyst (value inflection) update?
N/A
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}